Advertisement
case study hepatitis a: Case Studies in Medical Toxicology Leslie R. Dye, Christine Murphy, Diane P. Calello, Michael D. Levine, Aaron Skolnik, 2017-12-22 The ACMT National Case Conference (NCC) is a monthly discussion of novel or interesting cases in medical toxicology. Participation is through online webinar, and the conferences are recorded to allow for review at any time. The cases in this book are taken from recordings of NCC with edits and revisions by contributors and editors to demonstrate educational points. The majority of the case information is from the original recording and represents actual patient presentations. However, some of the details have been changed and fictional information added to enhance the educational value. This volume covers a broad range of toxicological topics, and specialty guidance is offered at the end of every case to aid non-toxicologists. The dilemmas are applicable to both academic and clinical medicine. A list of relevant questions is also provided for each case. Subjects include common toxicological problems, rare presentations of common problems, common problems with controversial treatments or difficult diagnoses, and rare problems. Case Studies in Medical Toxicology from the American College of Medical Toxicology is a detailed reference text on specific toxicological issues and also serves as a practical review for those taking board exams. As a result, this volume is an important and necessary resource for medical students, residents, and fellows, as well as primary-care physicians, intensivists, and toxicologistsCase Studies in Medical Toxicology from the American College of Medical Toxicology is a detailed reference text on specific toxicological issues and also serves as a practical review for those taking board exams. As a result, this volume is an important and necessary resource for medical students, residents, and fellows, as well as primary-care physicians, intensivists, and toxicologists. All proceeds from this book will be donated to the Medical Toxicology Foundation. |
case study hepatitis a: Infectious Diseases Case Study Approach Jonathan Cho, 2020-04-03 Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. A new case-based approach to teaching infectious disease pharmacotherapy to pharmacy students Reflecting the growing demand for healthcare providers versed in infectious disease pharmacotherapy, this innovative new text provides an essential examination of the subject through patient cases seen in actual practice. Assuming little prior knowledge of infectious diseases on the reader’s part, the text covers both common and uncommon presentations, as well as disease states not found in similar textbooks. Infectious Diseases: A Case Study Approach includes multiple-choice questions along with detailed explanations for both correct and incorrect answer choices, and valuable insight into each disease state. With this valuable resource, pharmacy students will learn how to apply pharmacotherapy concepts to real-world situations. Features: • Coverage of myriad disease states, including bacterial infections, prosthetic joint infections, bite wounds, encephalitis, and sexually transmitted diseases • Students will learn how to apply concepts to real-world situations • Includes enlightening clinical pearls for numerous disease states • Multiple-choice questions with complete answers, and more |
case study hepatitis a: Adverse Effects of Vaccines Institute of Medicine, Board on Population Health and Public Health Practice, Committee to Review Adverse Effects of Vaccines, 2012-04-26 In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors. |
case study hepatitis a: Foodborne Viruses M. en Duizer Koopmans (E.), Erwin Duizer, 2002 |
case study hepatitis a: Drug-Induced Liver Injury , 2019-07-13 Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series |
case study hepatitis a: Case Studies in Adult Intensive Care Medicine Daniele Bryden, Andrew Temple, 2017-04-20 This case-based approach to the intensive care medicine curriculum provides 48 case studies linking core knowledge to clinical context. Topics chosen have been mapped to eight key areas of study, making this ideal for both FFICM and EDIC exam candidates. |
case study hepatitis a: Case Studies in Public Health Theodore H. Tulchinsky, 2018-03-12 Case Studies in Public Health contains selected case studies of some of the most important and influential moments in medicine and epidemiology. The cases chosen for this collection represent a wide array of public health issues that go into the makeup of what can be termed the New Public Health (NPH), which includes traditional public health, such as sanitation, hygiene and infectious disease control, but widens its perspective to include the organization, financing and quality of health care services in a much broader sense. Each case study is presented in a systematic fashion to facilitate learning, with the case, background, current relevance, economic issues, ethical issues, conclusions, recommendation and references discussed for each case. The book is a valuable resource for advanced students and researchers with specialized knowledge who need further information on the general background and history of public health and important scientific discoveries within the field. It is an ideal resource for students in public health, epidemiology, medicine, anthropology, and sociology, and for those interested in how to apply lessons from the past to present and future research. - Explores the history of public health through important scientific events and flashpoints - Presents case studies in a clear, direct style that is easy to follow - Uses a systematic approach to help learn lessons from the past and apply them to the present |
case study hepatitis a: Studies on Hepatitis Viruses Satya Prakash Gupta, 2018-06-20 Studies on Hepatitis Viruses: Life Cycle, Structure, Functions, and Inhibition presents the latest on this systemic infection that predominantly affects the liver with inflammation that can be acute or chronic. Hepatitis viruses have been the subject of intense study in the last twenty years, with a wealth of information related to their lifecycle, structure, functions and inhibition being presented. This book compiles the most important developments and research, giving users a very useful guide on this evolving area of virology and medicinal chemistry. - Provides comprehensive, state-of-the-art coverage of hepatitis virus infections, the virus' lifecycle, and mechanisms of protease inhibition - Analyzes structure-activity relationships of inhibitors of viral hepatitis - Presents an in-depth view of the structure and function of viral hepatitis - Discusses classification, epidemiology, pathogenesis, natural history, clinical manifestations, diagnosis, complications, associated disorders and animal models |
case study hepatitis a: Hepatitis A and Other Associated Hepatobiliary Diseases Costin Teodor Streba, Cristin Constantin Vere, Ion Rogoveanu, Valeria Tripodi, Silvia Lucangioli, 2020-05-13 Hepatitis A is a major health concern throughout the world. Its impact has largely been limited in recent times by the large-scale use of vaccines. It is, however, still rampant in various parts of the world, partly due to lack of medication, poor water access, and contaminated food products. This book provides comprehensive information on various aspects of hepatitis A with a focus on three of the most important biliary diseases: cholestasis, primary sclerosing cholangitis, and hemophagocytic lymphohistiocytosis. Chapters cover such topics as pathology, epidemiology, at-risk populations, animal research models, and future trends. |
case study hepatitis a: Eliminating the Public Health Problem of Hepatitis B and C in the United States National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C, 2016-06-01 Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report. |
case study hepatitis a: CDC Yellow Book 2018: Health Information for International Travel Centers for Disease Control and Prevention CDC, 2017-04-17 THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad. |
case study hepatitis a: Health Information for International Travel 2005-2006 Paul Arguin, 2005 |
case study hepatitis a: Permanent Supportive Housing National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Policy and Global Affairs, Science and Technology for Sustainability Program, Committee on an Evaluation of Permanent Supportive Housing Programs for Homeless Individuals, 2018-08-11 Chronic homelessness is a highly complex social problem of national importance. The problem has elicited a variety of societal and public policy responses over the years, concomitant with fluctuations in the economy and changes in the demographics of and attitudes toward poor and disenfranchised citizens. In recent decades, federal agencies, nonprofit organizations, and the philanthropic community have worked hard to develop and implement programs to solve the challenges of homelessness, and progress has been made. However, much more remains to be done. Importantly, the results of various efforts, and especially the efforts to reduce homelessness among veterans in recent years, have shown that the problem of homelessness can be successfully addressed. Although a number of programs have been developed to meet the needs of persons experiencing homelessness, this report focuses on one particular type of intervention: permanent supportive housing (PSH). Permanent Supportive Housing focuses on the impact of PSH on health care outcomes and its cost-effectiveness. The report also addresses policy and program barriers that affect the ability to bring the PSH and other housing models to scale to address housing and health care needs. |
case study hepatitis a: Clinical Case Studies for the Family Nurse Practitioner Leslie Neal-Boylan, 2011-11-28 Clinical Case Studies for the Family Nurse Practitioner is a key resource for advanced practice nurses and graduate students seeking to test their skills in assessing, diagnosing, and managing cases in family and primary care. Composed of more than 70 cases ranging from common to unique, the book compiles years of experience from experts in the field. It is organized chronologically, presenting cases from neonatal to geriatric care in a standard approach built on the SOAP format. This includes differential diagnosis and a series of critical thinking questions ideal for self-assessment or classroom use. |
case study hepatitis a: Guidelines for Foodborne Disease Outbreak Response , 2009 |
case study hepatitis a: Hepatitis and Liver Cancer Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Prevention and Control of Viral Hepatitis Infections, 2010-04-23 The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations. |
case study hepatitis a: A National Strategy for the Elimination of Hepatitis B and C National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C, 2017-07-30 Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them. |
case study hepatitis a: Viral Hepatitis in Children Mei-Hwei Chang, Kathleen B. Schwarz, 2019-07-15 This book is aimed to emphasize the rationale and importance of prevention and management of viral hepatitis in children, providing cutting edge knowledge. Viral hepatitis is a major health problem in the world. Although most complications of viral hepatitis are observed in adults, primary infection with hepatitis viruses often occurs during infancy or childhood. To better control viral hepatitis, prevention and therapy if possible should be started in childhood. This book offers updated and unique information about viral hepatitis in children, which has vitally important impact on global disease outcome and control, yet not discussed as frequently as viral hepatitis in adults in previous medical literature. Better prevention and management strategies are covered, starting from infancy and childhood, and even earlier during fetal life. It will be very helpful for better control of viral hepatitis both for daily practice and for developing future strategies and directions. If we can successfully control viral hepatitis in children, there will be very little remaining chronic hepatitis and related complications such as liver cirrhosis or hepatoma in adults. We hope readers, including medical students, researchers, pediatricians, family medicine physicians, infectious disease personnel, public health workers, gastroenterologists, hepatologists and parents of children with chronic hepatitis, will be benefited by reading this book. |
case study hepatitis a: Outbreak Investigations Around the World Dworkin, 2010-10-22 Accounts of field investigations, with much related personal information, written by scientists working in the field of epidemiology. |
case study hepatitis a: Case Files Eugene C. Toy, 2005 Presents 52 real-life clinical cases illustrating concepts in pharmacology. This book features Pharmacology Pearls to highlight points. It includes USMLE-style comprehension questions with each case. It also offers a primer on how to approach the basic sciences. |
case study hepatitis a: Epidemiology in Military and Veteran Populations Institute of Medicine, Medical Follow-Up Agency, 1991-02-01 This book contains papers presented at a conference which describe studies of a World War II hepatitis epidemic, a genetic analysis of substance use in veteran twins, hemorrhagic fever with renal syndrome, the psychological effects of military captivity, and dioxin in adipose tissue. Other papers discuss radiation risk studies in military populations and resources for epidemiologic research in Vietnam-era veterans. This volume should be of interest to epidemiologists, medical researchers, and others interested in public health. |
case study hepatitis a: Canadian Immunization Guide Canada. Comité consultatif national de l'immunisation, Canada. National Advisory Committee on Immunization, 2006 The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization. |
case study hepatitis a: Millions Saved Amanda Glassman, Miriam Temin, 2016-05-24 Over the past fifteen years, people in low- and middle-income countries have experienced a health revolution—one that has created new opportunities and brought new challenges. It is a revolution that keeps mothers and babies alive, helps children grow, and enables adults to thrive. Millions Saved: New Cases of Proven Success in Global Health chronicles the global health revolution from the ground up, showcasing twenty-two local, national, and regional health programs that have been part of this global change. The book profiles eighteen remarkable cases in which large-scale efforts to improve health in low- and middle-income countries succeeded, and four examples of promising interventions that fell short of their health targets when scaled-up in real world conditions. Each case demonstrates how much effort—and sometimes luck—is required to fight illness and sustain good health. The cases are grouped into four main categories, reflecting the diversity of strategies to improve population health in low-and middle-income countries: rolling out medicines and technologies; expanding access to health services; targeting cash transfers to improve health; and promoting population-wide behavior change to decrease risk. The programs covered also come from various regions around the world: seven from sub-Saharan Africa, six from Latin America and the Caribbean, five from East and Southeast Asia, and four from South Asia. |
case study hepatitis a: Clinical Hepatology Nora V. Bergasa, 2016-06-08 The aim of this book is to expand the knowledge of physicians in training, experienced clinicians, in the field of hepatology. The expansion of liver transplantation within hepatology, and the demanding care that patients in liver transplant hospital services require, have changed the focus of clinical hepatology to a surgical subspecialty, laced with immunology. There is a vacuum in the knowledge of classical hepatology in the developing physicians, and medical students that this book aims to fill. In this context, the experience in hospital and outpatient medicine in the care of patients with liver disease in public hospitals represents a source of information that will be made available to the readers. |
case study hepatitis a: Pharmacotherapy Principles and Practice Study Guide Michael D. Katz, Kathryn R. Matthias, Marie A. Chisholm-Burns, 2010-12-17 A case-based companion study guide to Pharmacotherapy Principles and Practice, 2e – learn how to apply your knowledge to actual patient situations Pharmacotherapy Principles and Practice Study Guide uses 98 cases to help you learn how to apply pharmacotherapeutic concepts to specific patient situations. Each case is presented in a consistent manner, similar to what you would see in a clinical setting and focuses on one primary topic or problem. Patients discussed in these cases will have drug therapy problems requiring identification and management. For each case, you will be asked to develop a Patient Database, Drug Therapy Problem Worksheet, and Pharmacotherapy Care Plan using the forms provided. These forms are adapted from those originally developed by the American Society of Health System Pharmacists Clinical Skills program. Each case includes: Learning Objectives Patient Presentation Targeted Questions followed by a hint that refers you to pages in Pharmacotherapy Principles and Practice, 2e where you can find the information to answer the question Follow-up Global Perspective which highlights an issue related to the case that is important to countries outside of North America or involve different ethnic groups or races Case Summary |
case study hepatitis a: Red Book American Academy of Pediatrics. Committee on Infectious Diseases, Larry K. Pickering, 2003 The 2003 Red Book, 26th Edition advances the Red Book's mission for the 21st century, with the most current information on clinical manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood infectious diseases. Developed with the assistance and advice of hundreds of physician contributors from across the country, the new edition contains a host of significant revisions, updates, and additions to its authoritative content. Includes active and passive immunization, recommendations for care of children in special circumstances, summaries of infectious diseases, antimicrobial agents and related therapy, antimicrobial prophylaxis, and useful appendices. |
case study hepatitis a: U.S. Agricultural Trade Update , 1990 |
case study hepatitis a: SARS Angela McLean, Robert May, John Pattison, Robin Weiss, 2005-03-10 |
case study hepatitis a: Case Studies in Pediatric Infectious Diseases Frank E. Berkowitz, 2007-08-13 This book features 121 case studies intended to provide an approach to the diagnosis and treatment of pediatric infectious diseases. Brief clinical scenarios are followed by discussions and supplemented with tables and photographs. The author considers infections caused by a wide spectrum of viral, bacterial, fungal, and parasitic infectious agents, as well as those affecting specific anatomic sites. The author addresses both common infections and those presenting a greater challenge in diagnosis. Discussions focus on principles of management, as opposed to details, and place emphasis on determining risk factors and on clinical evaluation, not on performing non-discriminating laboratory tests. The introductory chapter addresses general principles for the diagnosis and management of infectious diseases. The appendix contains extensive tables and lists pertaining to infectious agents and their epidemiology. The book is illustrated with high-quality color photographs and radiographs. Its readability provides an engaging way to study pediatric infectious diseases. |
case study hepatitis a: Environmental Medicine Committee on Curriculum Development in Environmental Medicine, Institute of Medicine, 1995-05-12 People are increasingly concerned about potential environmental health hazards and often ask their physicians questions such as: Is the tap water safe to drink? Is it safe to live near power lines? Unfortunately, physicians often lack the information and training related to environmental health risks needed to answer such questions. This book discusses six competency based learning objectives for all medical school students, discusses the relevance of environmental health to specific courses and clerkships, and demonstrates how to integrate environmental health into the curriculum through published case studies, some of which are included in one of the book's three appendices. Also included is a guide on where to obtain additional information for treatment, referral, and follow-up for diseases with possible environmental and/or occupational origins. |
case study hepatitis a: What I Need to Know about Hepatitis A. , 1999 |
case study hepatitis a: Case Files High-Risk Obstetrics Eugene C. Toy, Edward R. Yeomans, Linda Fonseca, Joseph M. Ernest, 2010-11-26 Real patients, real cases teach you high-risk obstetrics This is an excellent handbook on high risk obstetrics. The ideal audience is medical students or residents in the field who like real life scenarios to accentuate their learning. It is best suited for those in a time crunch, and residents and students certainly qualify. 3 Stars.--Doody's Review Service Case Files: High-Risk Obstetrics uses fifty clinical cases to illustrate evidence-based practice in high-risk obstetrics patients. Each case includes open-ended questions, extended discussion, Practice Pearls, a “Controversy” discussion, comprehension questions, and references to the most current literature with a brief critique of each article. This unique learning system teaches you to be a better clinician by learning in the context of real patients and reinforcing the latest evidence-based medicine. Features Clear and easy-to-follow case-based format helps residents and fellows develop clinical thinking skills Based on current journal articles and landmark studies, with an accompanying brief critique Practical Pearls give evidence-based recommendations for patient management Controversy feature discusses current controversies and different views related to each case Multiple-choice comprehension questions accompany each case Original line drawings and clinical images Proven learning system improves exam scores |
case study hepatitis a: Liver Disease in Children Frederick J. Suchy, Ronald J. Sokol, William F. Balistreri, 2007-05-07 Completely revised new edition of the premier reference on pediatric liver disease. Liver Disease in Children, 3rd Edition provides authoritative coverage of every aspect of liver disease affecting infants, children, and adolescents. The book offers an integrated approach to the science and clinical practice of pediatric hepatology and charts the substantial progress in understanding and treating these diseases. Chapters are written by international experts and address the unique pathophysiology, manifestations, and management of these disorders in the pediatric population. The third edition has been thoroughly updated and features new contributions on liver development, cholestatic and autoimmune disorders, fatty liver disease, and inborn errors of metabolism. With the continued evolution of pediatric hepatology as a discipline, this text remains an essential reference for all physicians involved in the care of children with liver disease. |
case study hepatitis a: Hepatitis Surveillance , 1987 |
case study hepatitis a: Haematology at a Glance Atul B. Mehta, Victor Hoffbrand, 2014-04-07 Following the familiar, easy-to-use at a Glance format, Haematology at a Glance, Fourth Edition is a broad and accessible introduction to the study of blood. Fully revised and updated to reflect advances in the field and in clinical practice, this new edition covers essential knowledge, from basic hematological physiology to blood disorders and their diagnosis and treatment. This new edition of Haematology at a Glance: • Features expanded sections on the underlying mechanisms, diagnostic techniques and management of the malignant haematological diseases. Also incorporates recent advances in knowledge of thrombosis and the newer oral anticoagulants • Contains the very latest clinical treatments • Includes updated illustrations and clinical photographs to illustrate concepts and aid understanding • Features extensive online self-assessment at www.ataglanceseries.com/haematology This book is an invaluable resource for medical students and health professionals wanting to consolidate and expand their knowledge of haematology. |
case study hepatitis a: Red Book 2021 David W. Kimberlin, Elizabeth Barnett, Ruth Lynfield, Mark H. Sawyer, 2021-05-15 The AAP's authoritative guide on preventing, recognizing, and treating more than 200 childhood infectious diseases. Developed by the AAP's Committee on Infectious Diseases as well as the expertise of the CDC, the FDA, and hundreds of physician contributors. |
case study hepatitis a: Enteric Hepatitis Viruses Stanley M. Lemon, Christopher M. Walker, 2018 A subject collection from Cold Spring Harbor Perspectives in Medicine--title page. |
case study hepatitis a: Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK) Gary D. Hammer, Stephen J. McPhee, 2014-03-22 A full-color, case-based review of the essentials of pathophysiology--covering all major organs and systems The goal of this trusted text is to introduce you to clinical medicine by reviewing the pathophysiologic basis of 120 diseases (and associated signs and symptoms) commonly encountered in medical practice. The authors, all experts in their respective fields, have provided a concise review of relevant normal structure and function of each body system, followed by a description of the pathophysiologic mechanisms that underlie several common diseases related to that system. Each chapter of Pathophysiology of Disease concludes with a collection of case studies and questions designed to test your understanding of the pathophysiology of each clinical entity discussed. These case studies allow you to apply your knowledge to specific clinical situations. Detailed answers to each case study question are provided at the end of the book. This unique interweaving of physiological and pathological concepts will put you on the path toward thinking about signs and symptoms in terms of their pathophysiologic basis, giving you an understanding of the why behind illness and treatment. Features 120 case studies (9 new) provide an opportunity for you to test your understanding of the pathophysiology of each clinical entity discussed Checkpoint questions provide review and appear in every chapter Updates and revisions throughout this new edition reflect the latest research and developments Numerous tables and diagrams encapsulate important information Updated references for each chapter topic Pathophysiology of Disease is a true must-have resource for medical students preparing for the USMLE Step 1 exam, as well as students engaged in their clerkship studies. House officers, nurses, nurse practitioners, physicians’ assistants, and allied health practitioners will find its concise presentation and broad scope a great help in facilitating their understanding of common disease entities. |
case study hepatitis a: Public Health Ethics: Cases Spanning the Globe Drue H. Barrett, Leonard W. Ortmann, Angus Dawson, Carla Saenz, Andreas Reis, Gail Bolan, 2016-04-20 This Open Access book highlights the ethical issues and dilemmas that arise in the practice of public health. It is also a tool to support instruction, debate, and dialogue regarding public health ethics. Although the practice of public health has always included consideration of ethical issues, the field of public health ethics as a discipline is a relatively new and emerging area. There are few practical training resources for public health practitioners, especially resources which include discussion of realistic cases which are likely to arise in the practice of public health. This work discusses these issues on a case to case basis and helps create awareness and understanding of the ethics of public health care. The main audience for the casebook is public health practitioners, including front-line workers, field epidemiology trainers and trainees, managers, planners, and decision makers who have an interest in learning about how to integrate ethical analysis into their day to day public health practice. The casebook is also useful to schools of public health and public health students as well as to academic ethicists who can use the book to teach public health ethics and distinguish it from clinical and research ethics. |
case study hepatitis a: The Belmont Report United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978 |
HEPATITIS A CASE REPORT - California Department of Public …
Confirmed hepatitis A case: anti-HAV IgM positive or epidemiologically linked with a laboratory-confirmed case Was the case employed as a health care worker with direct
Case Report on Hepatitis-A - jrmds.in
Introduction: Hepatitis is the inflammation of the liver which occurs from a variety of causes i.e. infectious and non-infectious, hepatitis A is caused due to picornavirus usually transmitted by …
Case study on viral hepatitis - wjbphs.com
Hepatitis is one of the most common infectious conditions in all age groups, from childhood to adults. The word 'viral' defines the condition as a result of viral infection in the inflamed liver, …
Factors Associated With Hepatitis A Mortality During Person …
We defined study cases as hepatitis A outbreak–associated patients who died and whose deaths were determined to be associated with hepatitis A by the respective state health department.
Outbreak of Hepatitis A Associated with Frozen Pomegranate …
Jul 23, 2014 · In May 2013, an outbreak of symptomatic hepatitis A virus (HEPATITIS A VIRUS) infections occurred in the United States. Federal, state, and local public health officials …
TOWARDS ELIMINATION OF VIRAL HEPATITIS - Ministry of …
This case study describes Malaysia’s journey towards eliminating viral hepatitis, showing the collaborative efforts to introduce hepatitis treatment and sustain prevention of hepatitis …
Case Report Hepatitis A: A Case Report Example of a Growing ...
Hepatitis A is a common worldwide cause of acute hepatitis. It has been classically associated with epidemics and is increasingly prevalent in the developing world. Generally, the illness is …
VIRAL HEPATITIS A CASE REPORT - LA County Department of …
VIRAL HEPATITIS A CASE REPORT – acd-hepA (12/23) Page 2 of 5 CONFIDENTIAL – This material is subject to the Official Information Privilege Act LABORATORY INFORMATION – …
Havrix® Waging War Against a Common Enemy: A Case Study
Hepatitis A is an acute, usually benign disease characterized by the inflammation of the liver that is transmitted through personal contact with oral secretions or stool as well as food and water …
Geetha Kumar: Ayurvedic Management In Hepatitis - A Case …
Acute Hepatitis case study which was successfully treated by Ayurvedic line of treatment. The signs and symp-toms, causes, patho-physiology of Hepatitis, along with its co-relation in …
Protecting against hepatitis: case study - nhmrc.gov.au
Protecting against hepatitis: Case Study Over the past century and throughout the world, viral hepatitis emerged as a significant public health issue afflicting hundreds of millions of people …
Case Report for Severe Hepatitis A Treated in a Korean Hospital
This case presents a classic case of severe hepatitis A in 2019 Korean outbreak, and is informative to physicians for diagnosis and treatment in the traditional Korean medicine field. …
Sowmiya.V et al: Ayurvedic management in hepatitis a w.s.r to ...
Ayurvedic treatment regimens were given in the management of hepatitis A (Yakrut shotha) for 30 days. In this case, significant improvements were monitored based on signs and symptoms …
use of a control bank to conduct a case-control study
An outbreak of 18 cases of hepatitis A virus infection across five Canadian provinces was investigated. Case onsets occurred between October 2017 and May 2018. A retrospective …
TB Case study - Utah
risk for HCV since Hepatitis C causes most cases of post-transfusion hepatitis and it is transmitted parenterally, usually through injection drug use (McCance & Huether, 2019). What’s more, …
Sowmiya.V et al: Ayurvedic management in hepatitis a w.s.r to ...
Ayurvedic treatment regimens were given in the management of hepatitis A (Yakrut shotha) for 30 days. In this case, significant improvements were monitored based on signs and symptoms …
Pathophysiology and Pharmacotherapy of a Patient with …
In this case report, we can identify that a patient afected with hepatitis by examining her physically, after laboratory test doctor confirmed that a patient was infected with reactive …
A Case Series of Children with Acute Hepatitis and Human …
Jul 13, 2022 · From October 1, 2021, to February 28, 2022, clinicians at Children’s of Alabama prospectively identified nine children with acute hepatitis (as defined below) of unknown cause …
Hepatitis A Case Study - plataforma.iphac.org
The majority of the case information is from the original recording and represents actual patient presentations. However, some of the details have been changed and fictional information …
Hepatitis A Outbreak Toolbox - World Health Organization …
• Case investigation form: Template case report form for acute viral hepatitis. Standard operating procedures for enhanced reporting of cases of acute hepatitis (Geneva: World Health …
HEPATITIS A CASE REPORT - California Department of …
Confirmed hepatitis A case: anti-HAV IgM positive or epidemiologically linked with a laboratory-confirmed case Was the case employed as a health care worker with direct
Case Report on Hepatitis-A - jrmds.in
Introduction: Hepatitis is the inflammation of the liver which occurs from a variety of causes i.e. infectious and non-infectious, hepatitis A is caused due to picornavirus usually transmitted by …
Case study on viral hepatitis - wjbphs.com
Hepatitis is one of the most common infectious conditions in all age groups, from childhood to adults. The word 'viral' defines the condition as a result of viral infection in the inflamed liver, …
Factors Associated With Hepatitis A Mortality During Person …
We defined study cases as hepatitis A outbreak–associated patients who died and whose deaths were determined to be associated with hepatitis A by the respective state health department.
Outbreak of Hepatitis A Associated with Frozen Pomegranate …
Jul 23, 2014 · In May 2013, an outbreak of symptomatic hepatitis A virus (HEPATITIS A VIRUS) infections occurred in the United States. Federal, state, and local public health officials …
TOWARDS ELIMINATION OF VIRAL HEPATITIS - Ministry of …
This case study describes Malaysia’s journey towards eliminating viral hepatitis, showing the collaborative efforts to introduce hepatitis treatment and sustain prevention of hepatitis …
Case Report Hepatitis A: A Case Report Example of a …
Hepatitis A is a common worldwide cause of acute hepatitis. It has been classically associated with epidemics and is increasingly prevalent in the developing world. Generally, the illness is …
VIRAL HEPATITIS A CASE REPORT - LA County Department …
VIRAL HEPATITIS A CASE REPORT – acd-hepA (12/23) Page 2 of 5 CONFIDENTIAL – This material is subject to the Official Information Privilege Act LABORATORY INFORMATION – …
Havrix® Waging War Against a Common Enemy: A Case Study
Hepatitis A is an acute, usually benign disease characterized by the inflammation of the liver that is transmitted through personal contact with oral secretions or stool as well as food and water …
Geetha Kumar: Ayurvedic Management In Hepatitis - A Case …
Acute Hepatitis case study which was successfully treated by Ayurvedic line of treatment. The signs and symp-toms, causes, patho-physiology of Hepatitis, along with its co-relation in …
Protecting against hepatitis: case study - nhmrc.gov.au
Protecting against hepatitis: Case Study Over the past century and throughout the world, viral hepatitis emerged as a significant public health issue afflicting hundreds of millions of people …
Case Report for Severe Hepatitis A Treated in a Korean Hospital
This case presents a classic case of severe hepatitis A in 2019 Korean outbreak, and is informative to physicians for diagnosis and treatment in the traditional Korean medicine field. …
Sowmiya.V et al: Ayurvedic management in hepatitis a w.s.r to ...
Ayurvedic treatment regimens were given in the management of hepatitis A (Yakrut shotha) for 30 days. In this case, significant improvements were monitored based on signs and symptoms …
use of a control bank to conduct a case-control study
An outbreak of 18 cases of hepatitis A virus infection across five Canadian provinces was investigated. Case onsets occurred between October 2017 and May 2018. A retrospective …
TB Case study - Utah
risk for HCV since Hepatitis C causes most cases of post-transfusion hepatitis and it is transmitted parenterally, usually through injection drug use (McCance & Huether, 2019). What’s more, …
Sowmiya.V et al: Ayurvedic management in hepatitis a w.s.r to ...
Ayurvedic treatment regimens were given in the management of hepatitis A (Yakrut shotha) for 30 days. In this case, significant improvements were monitored based on signs and symptoms …
Pathophysiology and Pharmacotherapy of a Patient with …
In this case report, we can identify that a patient afected with hepatitis by examining her physically, after laboratory test doctor confirmed that a patient was infected with reactive …
A Case Series of Children with Acute Hepatitis and Human …
Jul 13, 2022 · From October 1, 2021, to February 28, 2022, clinicians at Children’s of Alabama prospectively identified nine children with acute hepatitis (as defined below) of unknown cause …
Hepatitis A Case Study - plataforma.iphac.org
The majority of the case information is from the original recording and represents actual patient presentations. However, some of the details have been changed and fictional information …
Hepatitis A Outbreak Toolbox - World Health Organization …
• Case investigation form: Template case report form for acute viral hepatitis. Standard operating procedures for enhanced reporting of cases of acute hepatitis (Geneva: World Health …